Anebulo Pharmaceuticals, Inc.Anebulo Pharmaceuticals, Inc.Anebulo Pharmaceuticals, Inc.

Anebulo Pharmaceuticals, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪57.05 M‬USD
−0.36USD
‪−11.73 M‬USD
‪9.28 M‬
Beta (1Y)
−1.05

About Anebulo Pharmaceuticals, Inc.

CEO
Richard Anthony Cunningham
Headquarters
Lakeway
Employees (FY)
2
Founded
2020
FIGI
BBG00ZWY5GC8
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, ANEB-001, is currently in phase two of trial. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ANEB is 2.40 USD — it has increased by 9.09% in the past 24 hours. Watch Anebulo Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Anebulo Pharmaceuticals, Inc. stocks are traded under the ticker ANEB.
ANEB stock has fallen by 0.83% compared to the previous week, the month change is a 19.40% rise, over the last year Anebulo Pharmaceuticals, Inc. has showed a 4.80% increase.
ANEB reached its all-time high on May 21, 2021 with the price of 9.33 USD, and its all-time low was 1.62 USD and was reached on Oct 16, 2023. View more price dynamics on ANEB chart.
See other stocks reaching their highest and lowest prices.
ANEB stock is 9.01% volatile and has beta coefficient of −1.05. Track Anebulo Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Anebulo Pharmaceuticals, Inc. there?
Today Anebulo Pharmaceuticals, Inc. has the market capitalization of ‪57.05 M‬, it has decreased by 7.24% over the last week.
Yes, you can track Anebulo Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Anebulo Pharmaceuticals, Inc. is going to release the next earnings report on Sep 18, 2024. Keep track of upcoming events with our Earnings Calendar.
ANEB earnings for the last quarter are −0.06 USD per share, whereas the estimation was −0.12 USD resulting in a 48.57% surprise. The estimated earnings for the next quarter are −0.11 USD per share. See more details about Anebulo Pharmaceuticals, Inc. earnings.
Anebulo Pharmaceuticals, Inc. revenue for the last quarter amounts to 0 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
ANEB net income for the last quarter is ‪−1.65 M‬ USD, while the quarter before that showed ‪−2.72 M‬ USD of net income which accounts for 39.15% change. Track more Anebulo Pharmaceuticals, Inc. financial stats to get the full picture.
No, ANEB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 22, 2024, the company has 2.00 employees. See our rating of the largest employees — is Anebulo Pharmaceuticals, Inc. on this list?
Like other stocks, ANEB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Anebulo Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Anebulo Pharmaceuticals, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Anebulo Pharmaceuticals, Inc. stock shows the sell signal. See more of Anebulo Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.